<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H329671D1972341B9AD619C8EDBFC4DBD" public-private="public" key="H" bill-type="olc">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 3723 IH: Medical Device Electronic Labeling Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-05-25</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
<congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session>
<legis-num display="yes">H. R. 3723</legis-num>
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<action display="yes">
<action-date date="20230525">May 25, 2023</action-date>
<action-desc><sponsor name-id="O000019">Mr. Obernolte</sponsor> (for himself, <cosponsor name-id="K000382">Ms. Kuster</cosponsor>, <cosponsor name-id="C001120">Mr. Crenshaw</cosponsor>, and <cosponsor name-id="C001119">Ms. Craig</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
</action>
<legis-type>A BILL</legis-type>
<official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means.</official-title>
</form>
<legis-body id="H94597A748E96491EA593615B97DC037B" style="OLC"> 
<section id="H79B24D6EEE1E4F1686F210D42625FB9A" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medical Device Electronic Labeling Act</short-title></quote>.</text></section> <section id="H664FD08D636E4914BB7D6A4FD7A77379"><enum>2.</enum><header>Allowing required labeling of devices to be made available solely by electronic means</header><text display-inline="no-display-inline">Section 502(f) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/352">21 U.S.C. 352(f)</external-xref>) is amended by striking <quote>prescription devices intended for use in health care facilities or by a health care professional and required labeling for in vitro diagnostic devices intended for use by health care professionals or in blood establishments</quote> and inserting <quote>devices (including in vitro diagnostic devices)</quote>. </text></section> 
</legis-body>
</bill> 


